نتائج البحث

Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.

• Authors : Tanaka K; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Idaigaoka 1-1, Hasama, Yufu City, Oita, 879-5593, Japan. .; Mizusawa J

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Extremities/Extremities/Extremities/*pathology ; Sarcoma/Sarcoma/Sarcoma/*drug therapy

• Source: BMC cancer [BMC Cancer] 2019 Sep 06; Vol. 19 (1), pp. 890. Date of Electronic Publication: 2019 Sep 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Primary mediastinal dedifferentiated liposarcoma: Five case reports and a review.

• Authors : Miura, Kentaro¹ ; Hamanaka, Kazutoshi¹; Matsuoka, Shunichiro¹

• Source: Thoracic Cancer. Dec2018, Vol. 9 Issue 12, p1733-1740. 8p.

تفاصيل العنوان

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.

• Authors : Meguro A; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.; Ozaki K

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy; Aged

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2012 Jan; Vol. 53 (1), pp. 43-9. Date of Electronic Publication: 2011 Aug 24.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients.

• Authors : Kanbayashi, Yuko; Tsuchiya, Eren; Shimizu, Tadashi

Subjects: PHARMACOLOGY; RISK assessment; PERICARDIAL effusionJAPAN

• Source: DARU: Journal of Pharmaceutical Sciences; 4/26/2024, Vol. 32 Issue 1, p279-287, 9p

تفاصيل العنوان

Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.

• Authors : Endo M; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Kataoka T

Subjects: Sarcoma*/Sarcoma*/Sarcoma*/pathology ; Soft Tissue Neoplasms*/Soft Tissue Neoplasms*/Soft Tissue Neoplasms*/pathology ; Liposarcoma, Myxoid*

• Source: BMC cancer [BMC Cancer] 2023 Mar 08; Vol. 23 (1), pp. 219. Date of Electronic Publication: 2023 Mar 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan.

• Authors : Nishikawa, Hiroki¹ ; Osaki, Yukio¹ ; Kita, Ryuichi¹

• Source: Cancers. Mar2012, Vol. 4 Issue 1, p165-183. 19p. 3 Charts.

تفاصيل العنوان

Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis.

• Authors : Shu, Yujing¹; Hoshi, Sachi¹; Tomari, Shinsuke¹

• Source: Pathology International. Mar2002, Vol. 52 Issue 3, p214-223. 10p. 17 Black and White Photographs, 10 Diagrams.

تفاصيل العنوان

Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma.

• Authors : Tsutsué S; Celgene KK, Tokyo, Japan.; Tobinai K

Subjects: Health Care Costs*/Health Care Costs*/Health Care Costs*/statistics & numerical data ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/economics ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/mortality

• Source: PloS one [PLoS One] 2020 Aug 18; Vol. 15 (8), pp. e0237509. Date of Electronic Publication: 2020 Aug 18 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population.

• Authors : Shirouchi Y; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Yokoyama M

Subjects: Lymphoma, T-Cell, Peripheral*/Lymphoma, T-Cell, Peripheral*/Lymphoma, T-Cell, Peripheral*/drug therapy; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/therapeutic use

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2021 Aug; Vol. 62 (8), pp. 1869-1876. Date of Electronic Publication: 2021 Mar 10.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.

• Authors : Tanabe Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. .; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. .

Subjects: Polymorphism, Single Nucleotide*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

• Source: BMC cancer [BMC Cancer] 2020 Apr 16; Vol. 20 (1), pp. 325. Date of Electronic Publication: 2020 Apr 16.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان